Moreover, would multiple altered pathways, such as enhanced glycogen metabolism in the context of resistance to TGF-β signaling, act in an additive or in a synergistic manner as it pertains to enhancement of T cell function with resultant tumor control? This evidence concerns the gene TGFB1 and neoplasm.